HCA Healthcare Q4 EPS $8.14 (up 44.6%), revenue $19.5B, $10B buyback authorized

HCA Healthcare, Inc.

2025-FY EPS reported $28.33 revenue$75,600,000,000

Q4 revenue $19.513B (+6.7% YoY); net income $1.878B (+30.6%); adjusted EBITDA $4.114B (+10.8%).
Diluted EPS $8.14 (+44.6%), adjusted EPS $8.01 (+28.8%); same-facility admissions +2.4%, equivalent admissions +2.5%.
Board authorized new $10B share repurchase program; $750M remained under prior authorization as of Dec 31.
Quarterly dividend raised to $0.78/share, payable March 31, 2026 to holders of record March 17.
2026 guidance: revenue $76.5B-$80B, EPS $29.10-$31.50, adjusted EBITDA $15.55B-$16.45B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.